19-11133059-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000527.5(LDLR):​c.*1743C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 151,446 control chromosomes in the GnomAD database, including 10,223 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 10219 hom., cov: 30)
Exomes 𝑓: 0.54 ( 4 hom. )

Consequence

LDLR
NM_000527.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.84

Publications

17 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
SPC24 (HGNC:26913): (SPC24 component of NDC80 kinetochore complex) Predicted to be involved in cell division. Located in nucleolus and nucleoplasm. Part of Ndc80 complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 19-11133059-C-T is Benign according to our data. Variant chr19-11133059-C-T is described in ClinVar as Benign. ClinVar VariationId is 328106.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.*1743C>T
3_prime_UTR
Exon 18 of 18NP_000518.1
LDLR
NM_001195798.2
c.*1743C>T
3_prime_UTR
Exon 18 of 18NP_001182727.1
LDLR
NM_001195799.2
c.*1743C>T
3_prime_UTR
Exon 17 of 17NP_001182728.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.*1743C>T
3_prime_UTR
Exon 18 of 18ENSP00000454071.1
LDLR
ENST00000252444.10
TSL:1
c.*1743C>T
3_prime_UTR
Exon 18 of 18ENSP00000252444.6
LDLR
ENST00000559340.2
TSL:5
n.*2395C>T
non_coding_transcript_exon
Exon 17 of 17ENSP00000453696.2

Frequencies

GnomAD3 genomes
AF:
0.332
AC:
50200
AN:
151302
Hom.:
10228
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0876
Gnomad AMI
AF:
0.308
Gnomad AMR
AF:
0.427
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.191
Gnomad SAS
AF:
0.374
Gnomad FIN
AF:
0.499
Gnomad MID
AF:
0.426
Gnomad NFE
AF:
0.437
Gnomad OTH
AF:
0.368
GnomAD4 exome
AF:
0.542
AC:
13
AN:
24
Hom.:
4
Cov.:
0
AF XY:
0.438
AC XY:
7
AN XY:
16
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.611
AC:
11
AN:
18
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.331
AC:
50187
AN:
151422
Hom.:
10219
Cov.:
30
AF XY:
0.336
AC XY:
24834
AN XY:
73938
show subpopulations
African (AFR)
AF:
0.0875
AC:
3613
AN:
41286
American (AMR)
AF:
0.426
AC:
6460
AN:
15158
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1332
AN:
3464
East Asian (EAS)
AF:
0.191
AC:
975
AN:
5118
South Asian (SAS)
AF:
0.374
AC:
1796
AN:
4802
European-Finnish (FIN)
AF:
0.499
AC:
5216
AN:
10454
Middle Eastern (MID)
AF:
0.414
AC:
120
AN:
290
European-Non Finnish (NFE)
AF:
0.437
AC:
29625
AN:
67840
Other (OTH)
AF:
0.367
AC:
770
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1480
2960
4441
5921
7401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
494
988
1482
1976
2470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.338
Hom.:
3211
Bravo
AF:
0.314
Asia WGS
AF:
0.258
AC:
896
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.099
DANN
Benign
0.47
PhyloP100
-3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2738467; hg19: chr19-11243735; API